Our analysis showed that MT1-MMP and MT5-MMP expression and MFI were higher on CD8+CD20+ T cells than CD8+CD20- T cells and more pronounced in patients with MS than controls. This evidence concerns the gene MMP24 and myeloid sarcoma.